1. Home
  2. BLDE vs AMRN Comparison

BLDE vs AMRN Comparison

Compare BLDE & AMRN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BLDE
  • AMRN
  • Stock Information
  • Founded
  • BLDE 2014
  • AMRN 1989
  • Country
  • BLDE United States
  • AMRN Ireland
  • Employees
  • BLDE N/A
  • AMRN N/A
  • Industry
  • BLDE Aerospace
  • AMRN Biotechnology: Pharmaceutical Preparations
  • Sector
  • BLDE Consumer Discretionary
  • AMRN Health Care
  • Exchange
  • BLDE Nasdaq
  • AMRN Nasdaq
  • Market Cap
  • BLDE 257.2M
  • AMRN 234.4M
  • IPO Year
  • BLDE N/A
  • AMRN 1993
  • Fundamental
  • Price
  • BLDE $3.45
  • AMRN $0.58
  • Analyst Decision
  • BLDE
  • AMRN Hold
  • Analyst Count
  • BLDE 0
  • AMRN 3
  • Target Price
  • BLDE N/A
  • AMRN $1.00
  • AVG Volume (30 Days)
  • BLDE 489.2K
  • AMRN 692.1K
  • Earning Date
  • BLDE 11-06-2024
  • AMRN 10-30-2024
  • Dividend Yield
  • BLDE N/A
  • AMRN N/A
  • EPS Growth
  • BLDE N/A
  • AMRN N/A
  • EPS
  • BLDE N/A
  • AMRN N/A
  • Revenue
  • BLDE $238,379,000.00
  • AMRN $264,779,000.00
  • Revenue This Year
  • BLDE $12.14
  • AMRN N/A
  • Revenue Next Year
  • BLDE $11.35
  • AMRN N/A
  • P/E Ratio
  • BLDE N/A
  • AMRN N/A
  • Revenue Growth
  • BLDE 25.39
  • AMRN N/A
  • 52 Week Low
  • BLDE $2.06
  • AMRN $0.56
  • 52 Week High
  • BLDE $4.25
  • AMRN $1.37
  • Technical
  • Relative Strength Index (RSI)
  • BLDE 62.96
  • AMRN 42.70
  • Support Level
  • BLDE $2.86
  • AMRN $0.57
  • Resistance Level
  • BLDE $3.33
  • AMRN $0.62
  • Average True Range (ATR)
  • BLDE 0.16
  • AMRN 0.03
  • MACD
  • BLDE 0.05
  • AMRN 0.00
  • Stochastic Oscillator
  • BLDE 87.07
  • AMRN 18.00

About BLDE Blade Air Mobility Inc.

Blade Air Mobility Inc is a technology-powered air mobility platform that provides air transportation and logistics for hospitals and is a transporter of human organs for transplant, and for passengers, with helicopter and fixed-wing services predominantly in the Northeast United States, Southern Europe and Western Canada. The company's operating segments are; Passenger, and Medical. Majority of the revenue for the company is generated from its Medical segment which predominantly consists of transportation of human organs for transplant and the medical teams supporting these services. It also offers additional services including donor logistics coordination and support in evaluating potential donor organs. A substantial portion of the company's revenue is generated from the United States.

About AMRN Amarin Corporation plc

Amarin Corp PLC is a biopharmaceutical company. It is focused on the commercialization and development of therapeutics to improve cardiovascular, or CV, health and reduce CV risk. Its commercialized product includes Vascepa.

Share on Social Networks: